Literature DB >> 19438726

Overexpression of human histone methylase MLL1 upon exposure to a food contaminant mycotoxin, deoxynivalenol.

Khairul I Ansari1, Imran Hussain, Hriday K Das, Subhrangsu S Mandal.   

Abstract

Mixed lineage leukemias (MLLs) are histone-methylating enzymes with critical roles in gene expression, epigenetics and cancer. Although MLLs are important gene regulators little is known about their own regulation. Herein, to understand the effects of toxic stress on MLL gene regulation, we treated human cells with a common food contaminant mycotoxin, deoxynivalenol (DON). Our results demonstrate that MLLs and Hox genes are overexpressed upon exposure to DON. Studies using specific inhibitors demonstrated that Src kinase families are involved in upstream events in DON-mediated upregulation of MLL1. Sequence analysis demonstrated that the MLL1 promoter contains multiple Sp1-binding sites and importantly, the binding of Sp1 is enriched in the MLL1 promoter upon exposure to DON. Moreover, antisense-mediated knockdown of Sp1 diminished DON-induced MLL1 upregulation. These results demonstrated that MLL1 gene expression is sensitive to toxic stress and Sp1 plays crucial roles in the stress-induced upregulation of MLL1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438726     DOI: 10.1111/j.1742-4658.2009.07055.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

2.  Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

3.  HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment.

Authors:  Khairul I Ansari; Imran Hussain; Bishakha Shrestha; Sahba Kasiri; Subhrangsu S Mandal
Journal:  J Mol Biol       Date:  2011-06-12       Impact factor: 5.469

Review 4.  Challenges and opportunities in targeting the menin-MLL interaction.

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

Review 5.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

6.  Histone methylases MLL1 and MLL3 coordinate with estrogen receptors in estrogen-mediated HOXB9 expression.

Authors:  Khairul I Ansari; Bishakha Shrestha; Imran Hussain; Sahba Kasiri; Subhrangsu S Mandal
Journal:  Biochemistry       Date:  2011-04-05       Impact factor: 3.162

7.  Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol.

Authors:  Arunoday Bhan; Imran Hussain; Khairul I Ansari; Sahba Kasiri; Aarti Bashyal; Subhrangsu S Mandal
Journal:  J Mol Biol       Date:  2013-01-31       Impact factor: 5.469

8.  Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue.

Authors:  Bishakha Shrestha; Khairul I Ansari; Arunoday Bhan; Sahba Kasiri; Imran Hussain; Subhrangsu S Mandal
Journal:  FEBS J       Date:  2012-08-31       Impact factor: 5.542

9.  Histone methylase MLL1 has critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo.

Authors:  K I Ansari; S Kasiri; S S Mandal
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

Review 10.  From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol.

Authors:  Marc Maresca
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.